Holen Sie sich die Stockscreener-App
1.715
0.88%
0.015
Schlusskurs vom Vortag:
$1.70
Offen:
$1.71
24-Stunden-Volumen:
38,489
Relative Volume:
0.15
Marktkapitalisierung:
$96.76M
Einnahmen:
$16.45M
Nettoeinkommen (Verlust:
$-73.60M
KGV:
-1.3404
EPS:
-1.2795
Netto-Cashflow:
$-46.25M
1W Leistung:
+2.08%
1M Leistung:
-3.65%
6M Leistung:
-24.12%
1J Leistung:
+0.29%
1-Tages-Spanne:
$1.70
$1.7181
1-Wochen-Bereich:
$1.65
$1.7181
52-Wochen-Spanne:
$1.64
$2.41
Seer Inc Stock (SEER) Company Profile
Firmenname
Seer Inc
Sektor
Branche
Telefon
650-453-0000
Adresse
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
1.715 | 95.92M | 16.45M | -73.60M | -46.25M | -1.2795 |
VRTX
Vertex Pharmaceuticals Inc
|
433.89 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
762.93 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
747.85 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.40 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.62 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-05 | Fortgesetzt | JP Morgan | Neutral |
| 2023-01-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-08-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2020-12-29 | Eingeleitet | BofA Securities | Neutral |
| 2020-12-29 | Eingeleitet | Cowen | Outperform |
| 2020-12-29 | Eingeleitet | JP Morgan | Overweight |
| 2020-12-29 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Seer Inc Aktie (SEER) Neueste Nachrichten
Weekly Recap: What is the target price for Seer Inc stockCEO Change & Scalable Portfolio Growth Methods - baoquankhu1.vn
Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries - 富途牛牛
Whale Trades: Can Seer Inc deliver consistent EPS growth2026 Patterns & Weekly Consistent Profit Watchlists - baoquankhu1.vn
BRKR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Fundamentals Check: Is now the right time to enter Seer Inc2026 Catalysts & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Bruker, Seer Each Claim Partial Win in US Patent Board Ruling - 富途牛牛
Seer, Inc. (NASDAQ:SEER) Sees Large Decline in Short Interest - MarketBeat
Seer retains patent claims in USPTO review of protein analysis tech - Investing.com Australia
Seer Strengthens Proteograph IP Following Favorable Patent Ruling - tipranks.com
PTAB upholds key Seer (Nasdaq: SEER) Proteograph patent claims - Stock Titan
Nasdaq Moves: Whats next for Seer Inc stockAnalyst Downgrade & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Patent fight ends with Seer keeping 23 claims tied to its protein platform - Stock Titan
Bullish Seer Insiders Loaded Up On US$5.29m Of Stock - Yahoo Finance
Risk Recap: Will Seer Inc outperform the market in YEAR2026 Sector Moves & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Analyst Downgrade: Does Seer Inc meet Warren Buffetts criteriaTake Profit & Real-Time Buy Signal Notifications - baoquankhu1.vn
US Market Wrap: Should you avoid Seer Inc stock right now2026 Big Picture & Real-Time Volume Analysis Alerts - baoquankhu1.vn
TD Cowen Maintains Seer Inc(SEER.US) With Buy Rating - 富途牛牛
Seer (NASDAQ:SEER) Shares Down 2.6%Here's What Happened - MarketBeat
SEER Should I Buy - Intellectia AI
SEER.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
SEER.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SEER News & Events - Intellectia AI
SEER.O Technical Analysis & Stock Price Forecast - Intellectia AI
Retail Trends: What is the target price for Seer Inc stockProduct Launch & Daily Oversold Bounce Ideas - baoquankhu1.vn
Seer Inc stock (ISIN: US8158581079) gains traction as protein-analysis platform expands clinical ado - AD HOC NEWS
Seer, Inc. Announces Amendment No. 1 to Tax Benefit Preservation Plan in Latest 8-K Filing - Minichart
Seer amends tax benefit plan and agrees to $250,000 mootness fee in stockholder suit By Investing.com - Investing.com India
Seer amends tax benefit plan and agrees to $250,000 mootness fee in stockholder suit - Investing.com Nigeria
Seer Amends Tax Benefit Plan After Stockholder Challenge - TipRanks
Seer (NASDAQ: SEER) updates tax benefit plan after Delaware action - Stock Titan
Aug PostEarnings: Will Seer Inc stock recover after earningsTrade Exit Report & Short-Term Swing Trade Alerts - baoquankhu1.vn
Setup Watch: What is the target price for Seer Inc stock2025 Market WrapUp & Precise Swing Trade Alerts - baoquankhu1.vn
Aug Sectors: Is now the right time to enter Seer IncWeekly Gains Report & Safe Capital Growth Stock Tips - baoquankhu1.vn
Sentiment Watch: Whats the fair value of AEV CL stockAnalyst Downgrade & Low Risk Investment Opportunities - baoquankhu1.vn
Sectors Review: Can Seer Inc be recession proof2025 Price Momentum & Weekly High Momentum Picks - baoquankhu1.vn
Aug Volume: What is the target price for Seer Inc stockEarnings Beat & Community Shared Stock Ideas - baoquankhu1.vn
SEER: Strong growth, innovation, and new detector tech set the stage for future expansion - TradingView
Bradley Radoff Sends Open Letter to Seer, Inc. - marketscreener.com
Seer (SEER) Stockholders Express Concerns Over Management and Fi - GuruFocus
Incorrect alert on Seer Inc's forecast withdrawn - marketscreener.com
Radoff-Jec Group calls on Seer board to announce sale process - marketscreener.com
The Radoff-JEC Group Sends Open Letter to Seer, Inc. Unconflicted Independent Directors Meeta Gulyani and Nicolas Roelofs - Stock Titan
SEER Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Activist group in Seer (SEER) reports 7.6% stake and opposes NOL pill - Stock Titan
Seer (NASDAQ: SEER) expands Proteograph platform and targets $30B proteomics market - Stock Titan
Seer 10-K: Revenue $16.58M, EPS $(1.28) - TradingView
Tranche Update on Seer, Inc.'s Equity Buyback Plan announced on May 8, 2024. - marketscreener.com
Seer Inc. Balances Growth Momentum With Cautious Outlook - TipRanks
Seer, Inc. (NASDAQ:SEER) Q4 2025 Earnings Call Transcript - Insider Monkey
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Seer Q4 Earnings Call Highlights - Yahoo Finance
Finanzdaten der Seer Inc-Aktie (SEER)
Umsatz
Nettogewinn
Free Cashflow
ENV
Seer Inc-Aktie (SEER) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Farokhzad Omid | CEO AND CHAIR |
Feb 18 '26 |
Sale |
1.99 |
24,385 |
48,646 |
3,349,064 |
| Horn David R. | PRESIDENT & CFO |
Nov 19 '25 |
Sale |
1.97 |
6,797 |
13,400 |
436,802 |
| Farokhzad Omid | CEO AND CHAIR |
Nov 19 '25 |
Sale |
1.97 |
33,838 |
66,708 |
1,238,230 |
| Horn David R. | PRESIDENT & CFO |
Aug 20 '25 |
Sale |
2.04 |
6,827 |
13,955 |
436,802 |
| Farokhzad Omid | CEO AND CHAIR |
Aug 20 '25 |
Sale |
2.04 |
33,992 |
69,483 |
1,272,068 |
| Nishar Dipchand | Director |
Jun 13 '25 |
Sale |
2.08 |
30,253 |
62,935 |
49,204 |
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):